Estimating active bone marrow dose from occupational exposure to uranium at a former gaseous diffusion plant

Health Physics

Volumn 93, Issue 2, 2007, Pages 113-119

  Anderson, J L ^b   Spitz, H B ^b   Yiin, J H ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NONE

Author keywords

Bone marrow; Dose; Exposure, occupational; Uranium

Indexed keywords

FLUORINE DERIVATIVE; UNCLASSIFIED DRUG; URANIUM 234; URANIUM 235; URANIUM 236; URANIUM 238; URANIUM DERIVATIVE;

ARTICLE; BIOASSAY; BONE MARROW EXAMINATION; CONTROLLED STUDY; DOSIMETRY; FLUOROMETRY; HUMAN; NUCLEAR INDUSTRY; OCCUPATIONAL EXPOSURE; PERSONNEL RADIATION MONITORING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SOLUBILITY; URINALYSIS; URINARY EXCRETION;

BODY BURDEN; BONE MARROW; HUMANS; OCCUPATIONAL EXPOSURE; RADIATION DOSAGE; URANIUM;

EID: 34447331460     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HP.0000261161.20101.36     Document Type: Article

References (23)

1. Archer VE, Wagoner JK, Lundin FE Jr. Cancer mortality among uranium mill workers. J Occup Med 15:11-14; 1973.
2. Beaumont JJ, Steenland K, Minton A, Meyer S. A computer program for incidence density sampling of controls in case-control studies nested within occupational cohort studies. Am J Epidemiol 129:212-219; 1989.
3. Blair A, Hayes HM. Mortality patterns among U.S. veterinarians, 1947-1977: an expanded study. Int J Epidemiol 11:391-397; 1982.
4. Boecker B, Hall R, Inn K, Lawrence J, Ziemer P, Eisele G, Wachholz B, Burr Jr W. Current status of bioassay procedures to detect and quantify previous exposures to radioactive materials. Health Phys 60(Suppl 1):45-100; 1991.
5. Brodsky A. Cumulative lognormal distributions of dose-response vs. dose distributions. In: Proceedings of the 10th International Congress of the International Radiation Protection Association, Hiroshima, Japan. Tokai, Japan: IRPA; 2000. Available at http://www2000.irpa.net/pub/pr/index.html. Accessed 21 May 2007.
6. da Motta LC, da Horta JS, Tavares MH. Prospective epidemiological study of Thorotrast-exposed patients in Portugal. Environ Res 18:152-172; 1979.
7. Department of Health and Human Services. Third national report on human exposure to environmental chemicals. Atlanta, GA: DHHS; Centers for Disease Control and Prevention; National Center for Environmental Health; Pub. No. 05-0570; 2005.
8. Faber M. Twenty-eight years of continuous follow-up of patients injected with Thorotrast for cerebral angiography. Environ Res 18:37-43; 1979.
9. th Annual Meeting of the Air and Waste Management Association. Pittsburgh, PA: Air and Waste Management Association; 1995. Available at http://www4.ncsu.edu/~frey/Frey_Cullen95.pdf. Accessed 21 May 2007.
10. Garland M, Morris JS, Rosner BA, Stampfer MJ, Spate VL, Baskett CJ, Willett WC, Hunter DJ. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2:493-497; 1993.
11. International Commission on Radiological Protection. Report of the Task Group on Reference Man. Elmsford, NY: Pergamon Press; ICRP Publication 23; 1975.
12. International Commission on Radiological Protection. Human respiratory tract model for radiological protection. Tarrytown, NY: Elsevier Science Inc.; ICRP Publication 66; 1994.
13. Lewis EB. Leukemia, multiple myeloma and aplastic anemia in American radiologists. Science 142:1492-1494; 1963.
14. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, Bernstein L, Hartge P. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Persp 112:1691-1696; 2004.
15. Matanoski GM, Seltser R, Sartwell PE, Diamond EL, Elliott EA. The current mortality rates of radiologists and other physician specialists: specific causes of death. Am J Epidemiol 101:199-210; 1975.
16. National Council on Radiation Protection and Measurements. Exposure of the population in the United States and Canada from natural background radiation. Recommendations of the National Council on Radiation Protection and Measurements. Bethesda, MD: NCRP; Report No. 94; 1987.
17. Polednak AP, Stehney AF, Rowland RE. Mortality among women first employed before 1930 in the U.S. radium dial-painting industry. A group ascertained from employment lists. Am J Epidemiol 197:179-195; 1978.
18. Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Nonaka H, Thompson DE, Soda M, Mabuchi K. Cancer incidence in atomic bomb survivors. Part III: leukemia, lymphoma, and multiple myeloma, 1950-1987. Radiat Res 137(Suppl 2):S68-S97; 1994.
19. Rich B, Hinnefeld S, Lagerquist C, Mansfield G, Munson L, Wagner E. Health physics manual of good practices for uranium facilities. Idaho Falls: U.S. Department of Energy, Idaho National Engineering Lab; EGG-2530, DE88-103620; 1988.
20. Statistics, Epidemiology and End Result. Ries LAG, Harkins D, Krapcho M, MariottoA. Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK, eds. SEER cancer statistics review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006. Available at: http://seer.cancer.gov/csr/1975_2003/ Accessed 30 September 2006.
21. Stebbings JH, Lucas HF, Stehney AF. Mortality from cancers of major sites in female radium dial workers. Am J Ind Med 5:435-459; 1984.
22. van Kaick G, Lorenz D, Muth H, Kaul A. Malignancies in German Thorotrast patients and estimated tissue dose. Health Phys 35:127-136; 1978.
23. Wagoner JK, Archer VF, Carroll BE, Holaday DA, Lawrence PA. Cancer mortality patterns among U.S. uranium miners and millers, 1950 through 1962. J Nat Cancer Inst 32:787-801; 1964.